microdosing glp 1 for arthritis GLP-1s: Reduce Inflammation, Support Cognitive Health, and More — Dr. Michelle Weiner at NeuroPain Health How microdosing GLP-1 drugs became

Instead of relying on quarterly summaries or annual reviews, teams gain a live view of what's happening across their pharmacy program, allowing them to identify issues sooner and make informed decisions while there is still time to influence outcomes

That openness is the pitch, and it undercuts Peak Wellnesss month-to-month rate

Cox proportional hazards regression models were used to estimate adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) for study outcomes

When a cardiologist's primary clinical mandate is preventing heart attacks and strokes, and a drug demonstrates 20% reduction in major cardiovascular events, that drug becomes a cardiovascular medicine rather than a metabolic medicine

This allows the body time to adapt and tolerate the medication while minimizing side effects

"We really need a lot more studies focused on GLP-1 use in this particular patient population, because the majority of what we have is on older adults and diabetes," she says